Probucol | hsa00030 | Pentose phosphate pathway | 3.33E-03 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | |
Probucol | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Probucol | hsa00562 | Inositol phosphate metabolism | 1.28E-02 | 2 | Q14642, P29218 | INPP5A, IMPA1 | More | |
Probucol | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Probucol | hsa00830 | Retinol metabolism | 3.49E-02 | 1 | P00325 | ADH1B | More | |
Probucol | hsa01100 | Metabolic pathways | 4.12E-02 | 6 | Q14642, P29218, Q14376, P07101, Q9UHK6, P12074 | INPP5A, IMPA1, GALE, TH, AMACR, COX6A1 | More | |
Probucol | hsa01230 | Biosynthesis of amino acids | 4.31E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | |
Probucol | hsa02010 | ABC transporters | 1.68E-03 | 1 | Q8IZY2 | ABCA7 | More | |
Probucol | hsa04014 | Ras signaling pathway | 4.65E-02 | 3 | Q15311, P0DP23, P17612 | RALBP1, CALM1, PRKACA | More | |
Probucol | hsa04070 | Phosphatidylinositol signaling system | 2.65E-02 | 2 | P29218, Q14642 | IMPA1, INPP5A | More | |
Probucol | hsa04114 | Oocyte meiosis | 2.15E-02 | 3 | P0DP23, P17612, Q13362 | CALM1, PRKACA, PPP2R5C | More | |
Probucol | hsa04144 | Endocytosis | 4.07E-03 | 5 | Q9H444, O75351, P42566, Q15438, Q14161 | CHMP4B, VPS4B, EPS15, PSCD1, GIT2 | More | |
Probucol | hsa04217 | Necroptosis | 4.56E-03 | 4 | P23458, Q9NQC7, Q9H444, O75351 | JAK1, CYLD, CHMP4B, VPS4B | More | |
Probucol | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.50E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
Probucol | hsa04610 | Complement and coagulation cascades | 2.52E-06 | 1 | P0C0L4 | C4A | More | |
Probucol | hsa04710 | Circadian rhythm | 3.74E-03 | 2 | O00327, O15055 | ARNTL, PER2 | More | |
Probucol | hsa04713 | Circadian entrainment | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Probucol | hsa04720 | Long-term potentiation | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Probucol | hsa04728 | Dopaminergic synapse | 1.55E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
Probucol | hsa04740 | Olfactory transduction | 6.71E-03 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Probucol | hsa04910 | Insulin signaling pathway | 3.62E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Probucol | hsa04916 | Melanogenesis | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Probucol | hsa04921 | Oxytocin signaling pathway | 1.84E-02 | 3 | P0DP23, P17612, Q96RR4 | CALM1, PRKACA, CAMKK2 | More | |
Probucol | hsa04924 | Renin secretion | 1.09E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Probucol | hsa04964 | Proximal tubule bicarbonate reclamation | 1.68E-03 | 1 | P00918 | CA2 | More | |
Probucol | hsa04966 | Collecting duct acid secretion | 1.68E-03 | 1 | P00918 | CA2 | More | |
Probucol | hsa04970 | Salivary secretion | 2.20E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Probucol | hsa04971 | Gastric acid secretion | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Probucol | hsa04976 | Bile secretion | 2.20E-02 | 2 | P17612, Q14032 | PRKACA, BAAT | More | |
Probucol | hsa04977 | Vitamin digestion and absorption | 3.43E-02 | 1 | P41440 | SLC19A1 | More | |
Probucol | hsa05031 | Amphetamine addiction | 2.87E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Probucol | hsa05034 | Alcoholism | 1.29E-02 | 3 | P17612, P0DP23, Q96RR4 | PRKACA, CALM1, CAMKK2 | More | |
Probucol | hsa05133 | Pertussis | 1.87E-03 | 1 | P0C0L4 | C4A | More | |
Probucol | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Probucol | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Probucol | hsa05212 | Pancreatic cancer | 2.87E-02 | 2 | Q15311, P23458 | RALBP1, JAK1 | More | |
Probucol | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.68E-03 | 1 | P54284 | CACNB3 | More | |